Renalytix RNLXY
OTC RNLXY
$3.70 -0.09 (-2.37%)
At close: Nov 6, 2026 · 4:00 PM EST

Renalytix (RNLXY) Equity Income (2020 - 2022)

Updated

Renalytix (RNLXY) posted Equity Income of -$9,000 for FY2023 (year ended Jun 30, 2023), compared with $9,000 in FY2022.

Analysis

Renalytix (RNLXY) Equity Income (2020 - 2022) Analysis & Trends

Since FY2020, Renalytix has reported Equity Income for 4 fiscal years.

  • Annual Equity Income has run from a low of -$2.11 million in FY2021 to a high of $9,000 in FY2022 over five years.
  • Business Quant data shows RNLXY's Equity Income at $9,000 in FY2022, -$2.11 million in FY2021 and -$63,000 in FY2020.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -9,000.00
Jun 30, 2022 -2,000.00
Mar 31, 2022 -26,000.00
Dec 31, 2021 37,000.00
Jun 30, 2021 -1.88 Mn
Mar 31, 2021 -8,000.00
Dec 31, 2020 -105,000.00
API Access

Renalytix Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=RNLXY&period=max&api_key=YOUR_API_KEY